OBJECTIVE: Continuous EEG (cEEG) monitoring of critically ill @entity1 has gained widespread use, but there is substantial reported variability in its use. We analyzed cEEG and antiseizure drug (ASD) usage at three high volume centers. METHODS: We utilized a multicenter cEEG database used daily as a clinical reporting tool in three tertiary care sites (Emory Hospital, Brigham and @entity1 's Hospital and Yale - New Haven Hospital). We compared the cEEG usage patterns, @entity410 frequency, detection of rhythmic/periodic patterns (RPP), and ASD use between the sites. RESULTS: 5792 cEEG sessions were analyzed. Indication for cEEG monitoring and recording duration were similar between the sites. @entity410 detection rate was nearly identical between the three sites, ranging between 12.3% and 13.6%. Median time to first @entity410 and detection rate of RPPs were similar. There were significant differences in doses of @entity4677 , @entity1092 , and @entity13876 used between the three sites. CONCLUSIONS: There was remarkable uniformity in @entity410 detection rates within three high volume centers. In contrast, dose of ASD used frequently differed between the three sites. SIGNIFICANCE: These large volume data are in line with recent guidelines regarding cEEG use. Difference in ASD use suggests discrepancies in how cEEG results influence @entity1 management.

The use and yield of continuous EEG in critically ill XXXX : A comparative study of three centers.

@entity1 :: ('9606', 'Species') :: ['patients', 'Women', 'patient'] @entity4677 :: ('MESH:C026098', 'Chemical') :: ['levetiracetam'] @entity410 :: ('MESH:D012640', 'Disease') :: ['seizure', 'Seizures'] @entity1092 :: ('MESH:D014635', 'Chemical') :: ['valproic acid'] @entity13876 :: ('MESH:C403507', 'Chemical') :: ['lacosamide']
@entity1 :: (9606,Species) :: ['patients']
